Research Article
Correlation between Acylcarnitine and Peripheral Neuropathy in Type 2 Diabetes Mellitus
Table 2
Acylcarnitine profile in T2DM patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
C0 = free carnitine; C2 = acetylcarnitine; C3 = propionylcarnitine; C4 = butyrylcarnitine; C4-OH = hydroxylbutyrylcarnitine; C4DC =succinylcarnitine; C5 = isovalerylcarnitine; C5-OH = 3-hydroxyisovalerylcarnitine; C5DC = glutarylcarnitine; C5:1 = tiglylcarnitine; C6 = hexanoylcarnitine; C8 = octanoylcarnitine; C10 = decanoylcarnitine; C12 = lauroylcarnitine; C14 = myristoylcarnitine; C14-OH = 3-hydroxyl-tetradecanoylcarnitine; C14DC = tetradecanoyldiacylcarnitine; C14:1 = tetradecenoylcarnitine; C16 = palmitoylcarnitine; C16-OH = 3-hydroxypalmitoylcarnitine; C16 = 1-OH, 3-hydroxypalmitoleylcarnitine; C18 = octadecanoylcarnitine; C20 = arachidic carnitine; C22 = behenic carnitine; C24 = tetracosanoic carnitine; C26 = hexacosanoic. |